医療シミュレーション装置・サービスの世界市場：患者シミュレーター、手術シミュレーター、血管内治療シミュレーター、超音波シミュレーター等...市場調査レポートについてご紹介

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKETS COVERED 20
1.3 MARKET SCOPE 21
1.4 STAKEHOLDERS 21
1.5 YEARS CONSIDERED IN THE REPORT 22
1.6 CURRENCY 22

2 RESEARCH METHODOLOGY 23
2.1 RESEARCH APPROACH 23
2.2 MARKET SIZE ESTIMATION 25
2.2.1 MARKET CRACKDOWN AND DATA TRIANGULATION 26
2.2.2 MARKET SHARE ESTIMATION 27
2.2.3 KEY DATA FROM SECONDARY SOURCES 28
2.2.4 KEY DATA FROM PRIMARY SOURCES 29
2.2.4.1 Key Industry Insights 30
2.3 ASSUMPTIONS FOR THE STUDY 31

3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 35
4.1 GROWTH POTENTIAL OF THE HEALTHCARE/MEDICAL SIMULATION MARKET 35
4.2 HEALTHCARE/MEDICAL SIMULATION MARKET IN ASIA-PACIFIC 36
4.3 HEALTHCARE/MEDICAL SIMULATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 37
4.4 PATIENT SIMULATORS MARKET: GEOGRAPHIC MIX 38
4.5 HEALTHCARE/MEDICAL SIMULATION MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 38

5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET SEGMENTATION 40
5.2.1 MEDICAL SIMULATION MARKET, BY PRODUCTS AND SERVICES 40
5.2.2 MEDICAL SIMULATION MARKET, BY END USER 41
5.3 MARKET DYNAMICS 42
5.3.1 DRIVERS 43
5.3.1.1 Increasing healthcare costs 44
5.3.1.2 Continuous innovations in technologies 44
5.3.1.3 Increasing demand for minimally invasive treatments 45
5.3.1.4 Increasing focus on patient safety 45
5.3.1.5 Growing industry consolidation 45
5.3.2 RESTRAINTS 46
5.3.2.1 Limited availability of funds 46
5.3.3 OPPORTUNITIES 47
5.3.3.1 Untapped emerging markets 47
5.3.3.2 Shortage of service providers 48
5.3.4 CHALLENGES 48
5.3.4.1 High cost of simulators 49
5.3.4.2 Operational challenges 49
5.3.4.2.1 Difficulty in achieving modeling and simulation of individual tissues 49
5.3.4.2.2 Difficulty in achieving multimodal simulation 49

6 INDUSTRY TRENDS 50
6.1 INTRODUCTION 50
6.2 INDUSTRY TRENDS 50
6.3 PORTER’S FIVE FORCES ANALYSIS 51
6.3.1 THREAT FROM NEW ENTRANTS 51
6.3.2 THREAT FROM SUBSTITUTES 52
6.3.3 BARGAINING POWER OF SUPPLIERS 52
6.3.4 BARGAINING POWER OF BUYERS 52
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 53
6.4 STRATEGIC BENCHMARKING 53
6.4.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENT 53

7 GLOBAL HEALTHCARE/MEDICAL SIMULATION PRODUCTS & SERVICES MARKET, BY TYPE 55
7.1 MANNEQUIN-BASED SIMULATION 58
7.1.1 PATIENT SIMULATORS 60
7.1.2 SURGICAL SIMULATORS 61
7.1.2.1 Laparoscopic Surgical Simulators 63
7.1.2.2 Arthroscopic Surgical Simulators 64
7.1.2.3 Cardiovascular Simulators 66
7.1.2.4 Gynecology simulators 67
7.1.2.5 Other Surgical Simulators 68
7.1.3 ENDOVASCULAR SIMULATORS 69
7.1.4 ULTRASOUND SIMULATORS 70
7.1.5 DENTAL SIMULATORS 71
7.1.6 EYE SIMULATORS 73
7.1.7 TASK TRAINERS 75
7.2 WEB-BASED SIMULATION 76
7.2.1 SERIOUS GAMES 77
7.2.2 SECOND LIFE 78
7.3 HEALTHCARE/MEDICAL SIMULATION SOFTWARE 79
7.3.1 PERFORMANCE RECORDING SOFTWARE 81
7.3.2 VIRTUAL TUTORS 82
7.4 HEALTHCARE/MEDICAL SIMULATION TRAINING SERVICES 83
7.4.1 VENDOR-BASED TRAINING 84
7.4.2 CUSTOM CONSULTING SERVICES 85
7.4.3 EDUCATIONAL SOCIETIES 86

8 MEDICAL SIMULATION MARKET, BY END USER 88
8.1 INTRODUCTION 89
8.2 ACADEMIC INSTITUTES 90
8.3 HOSPITALS 92
8.4 MILITARY ORGANIZATIONS 93

9 HEALTHCARE/MEDICAL SIMULATION MARKET, BY GEOGRAPHY 95
9.1 INTRODUCTION 96
9.2 NORTH AMERICA 98
9.2.1 U.S. 103
9.2.2 CANADA 107
9.3 EUROPE 110
9.3.1 GERMANY 116
9.3.2 U.K. 119
9.3.3 FRANCE 123
9.3.4 ITALY 126
9.3.5 SPAIN 130
9.3.6 REST OF EUROPE 134
9.4 ASIA-PACIFIC 138
9.4.1 JAPAN 143
9.4.2 CHINA 146
9.4.3 INDIA 150
9.4.4 REST OF ASIA-PACIFIC (ROAPAC) 153
9.5 REST OF THE WORLD 157
9.5.1 LATIN AMERICA 160
9.5.2 MIDDLE EAST AND AFRICA 164

10 COMPETITIVE LANDSCAPE 168
10.1 OVERVIEW 168
10.2 MARKET SHARE ANALYSIS 170
10.2.1 PATIENT SIMULATORS, BY KEY PLAYER 170
10.2.2 TASK TRAINERS, BY KEY PLAYER 171
10.2.3 PERFORMANCE RECORDING SOFTWARE, BY KEY PLAYER 172
10.3 COMPETITIVE SITUATION AND TRENDS 173
10.3.1 NEW PRODUCT LAUNCHES 174
10.3.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND ALLIANCES 175
10.3.3 MERGERS AND ACQUISITIONS 176
10.3.4 EXPANSIONS 177
10.3.5 OTHER DEVELOPMENTS 177

11 COMPANY PROFILES 179
11.1 3D SYSTEMS, INC. 179
11.2 CAE, INC. 187
11.3 KYOTO KAGAKU CO., LTD. 192
11.4 LAERDAL MEDICAL AS 195
11.5 LIMBS & THINGS, LTD 202
11.6 GAUMARD SCIENTIFIC COMPANY, INC. 211
11.7 MENTICE AB 217
11.8 SIMULAB CORPORATION 220
11.9 SIMULAIDS, INC. 228
11.10 SURGICAL SCIENCE SWEDEN AB 237
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

12 APPENDIX 240
12.1 INSIGHTS OF INDUSTRY EXPERTS 240
12.2 AVAILABLE CUSTOMIZATIONS 240
12.3 RELATED REPORTS 241
12.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 241